New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 31, 2014
11:29 EDTBRLI, DGX, LHFDA announces steps to ensure reliable diagnostic test results
The FDA announced that it took "important steps to ensure that certain tests used by health care professionals to help diagnose and treat patients provide accurate, consistent and reliable results." The FDA issued a final guidance on the development, review and approval of companion diagnostics, which are tests used to identify patients who will benefit from or be harmed by treatment with a certain drug. Companion diagnostic tests are intended to aid physicians in selecting appropriate therapies for individual patients, the agency said. These tests are commonly used to detect certain types of gene-based cancers. The FDA also is notifying Congress of its intention to publish a proposed risk-based oversight framework for laboratory developed tests, which are designed, manufactured and used within a single laboratory. The agency also intends to publish a draft guidance outlining how laboratories can notify the FDA that they are currently manufacturing and using LDTs, how to provide information about their LDTs, and how they can comply with the medical device reporting requirements. Publicly traded laboratory companies include LabCorp (LH), Quest Diagnostics (DGX) and Bio-Reference Labs (BRLI). Reference Link
News For LH;DGX;BRLI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 29, 2015
11:09 EDTDGXOptions with increasing implied volatility
Subscribe for More Information
09:16 EDTBRLIBofA/Merrill healthcare tech analyst holds analyst/industry conference call
Analyst Willoughby discusses relevant themes across the Healthcare Distribution & Technology subsectors on an Analyst/Industry conference call to be held on June 1 at 11 am.
07:07 EDTLHInternational Flavors names Alison Cornell as EVP, CFO, effective July 8
Subscribe for More Information
May 28, 2015
11:15 EDTDGXOptions with increasing implied volatility
Subscribe for More Information
May 27, 2015
10:36 EDTDGXOptions with increasing implied volatility
Options with increasing implied volatility: QUNR DGX FOSL BBBY ACN NKE EFA EMR
May 26, 2015
11:54 EDTDGXOptions with increasing implied volatility
Options with increasing implied volatility: VIPS DGX CVC JIVE LBTYA BBBY YHOO NKE CAN DTV
07:22 EDTLH, DGXDespite rumor, Quest takeover seems unlikely, says Wells Fargo
Subscribe for More Information
May 22, 2015
12:34 EDTLH, DGXOn The Fly: Top stock stories at midday
Subscribe for More Information
12:10 EDTLH, DGXQuest declines comment to Bloomberg on takeover speculation
Quest Diagnostics (DGX) declined comment to Bloomberg regarding the takeover speculation that pushed the company's stock higher today. Shares of Quest are up $7.01 to $80.89 in midday trading. Shares spiked earlier in the trading day amid talk among traders that Quest hired an investment bank to explore a sale after being approached by a suitor. The talk is unconfirmed speculation that has not been reported by any news agencies. Quest peer LabCorp (LH) is up $1.74 to $122.10 at midday.
10:46 EDTLHLabCorp volatility increases
Subscribe for More Information
10:43 EDTLH, DGXQuest Diagnostics jumps amid takeover speculation
The move higher in Quest Diagnostics (DGX), which was earlier halted for volatility and remains up 15% to $85 per share in morning trading, has been attributed to takeover speculation. Peer Lab Corp. (LH) is also up 3.9% to $125 in morning trading.
10:19 EDTDGXQuest Diagnostics calls active on renewed takeover chatter
Quest Diagnostics June 75 and 80 calls are active on total call volume of 2,100 contracts (100 puts) on renewed takeover chatter. June call option implied volatility is at 18, July is at 19; compared to its 26-week average of 19. Active call volume suggests traders taking positions for upside price movement.
10:15 EDTDGXRumor: Quest Diagnostics moves up on renewed takeover chatter
Subscribe for More Information
May 19, 2015
09:31 EDTLHORIG3N announces strategic collaboration with LabCorp
Subscribe for More Information
07:28 EDTLHUBS to hold a conference
Global Healthcare Conference is being held in New York on May 18-20 with webcasted company presentations to begin on May 19 at 8 am; not all company presentations may be webcasted. Webcast Link
May 18, 2015
08:46 EDTLHLabCorp announces full portfolio of Hep C virus drug resistance assays
LabCorp announced the launch of two new Hepatitis C Virus drug resistance assays. The HCV NS5A and NS5B Drug Resistance Assays expand LabCorpís portfolio of HCV resistance tests that includes HCV GenoSure NS3/4A, which was launched in 2011. These tests are available through Monogram Biosciences, a member of the LabCorp Specialty Testing Group, and a leader in the development and commercialization of innovative antiviral diagnostics.
07:22 EDTBRLIUBS to hold a conference
Global Healthcare Conference is being held in New York on May 18-20 with webcasted company presentations to begin on May 18 at 8 am; not all company presentations may be webcasted. Webcast Link

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use